Portfolio conflicts: distinguish useful adjacency from a real collision

Quick answer

Check portfolio conflicts by comparing the buyer, workflow and purchase decision of your company with the fund's relevant investments. Ask about direct overlap and information handling before sharing sensitive material. Record which companies and sources you checked, who will receive the deck, and what you can safely share next while questions remain open.

Updated 14 October 2026: added conflict types, a partner-level check, an ask-first script and FAQ.

Similar is not the same as competitive

Investor portfolio conflicts are a disclosure question before they are a ranking question. You want to know whether a conversation is sensible, what to share initially, and what needs clarification. You are not trying to label an entire sector off-limits.

An investor with relevant companies may understand your customer immediately. The same familiarity can create a collision if those companies sell a substitute to the same buyer. Both things can be true. A sector match should trigger inspection, not automatic enthusiasm or automatic rejection.

Start from the actual purchase decision. Who controls the budget? What job is the customer hiring the product to do? What would they stop buying if they bought your product? These questions are more useful than comparing two broad category labels.

Compare four dimensions

Create a short note for each plausible overlap:

• Buyer: the person or organization purchasing, not merely the end user.
• Workflow: the activity the product replaces, improves, or enables.
• Substitution: whether the buyer would choose one product instead of the other.
• Sensitive information: what your deck would reveal that could matter competitively.

Two products can share a user but draw from different budgets. A restaurant payroll product and a guest-reservation product both serve restaurants, but that fact alone does not establish competition. Conversely, products with different technology descriptions can compete for the same procurement decision.

Separate today's offer from a hypothetical future expansion. “They could eventually build this” is too weak to exclude every investor. An explicit product launch or current sales description deserves more attention than your imagination.

Choose the disclosure level for the overlap

Use the evidence about today's products to choose the next conversation. The table gives practical disclosure choices, not a score that clears an investor. A shared sector may warrant ordinary research; a substitute competing for the same budget calls for a specific conflict question before detailed commercial information leaves your team.

Check the firm's policy, not an industry myth

First Round distinguishes direct competition from later portfolio convergence and describes information separation. Its policy is not binding on other firms. First Round: How We Work.

Read the policy of the firm you are actually approaching. If none is supplied or visible, leave it unresolved. Do not invent a universal rule such as “funds never invest in competitors” or “different partners make it safe.”

A published portfolio may also be incomplete. Andreessen Horowitz explicitly cautions that featured investments are not representative of all investments. That illustrates why absence from a showcase should not become a declaration of clearance. a16z portfolio disclosure.

A fictional three-way review

Suppose the fictional company ClinicFlow sells appointment-capacity software to outpatient clinic managers.

Portfolio company North forms clinical diagnostic recommendations for physicians. There is sector adjacency, but no demonstrated substitute in the supplied descriptions. Mark “adjacent; no direct collision found in these materials,” not “no conflict exists.”

Portfolio company East sells scheduling and utilization software to those same clinic managers. The buyer, workflow, and purchasing decision overlap. Mark “possible direct conflict; clarify before sharing detailed strategy.”

Portfolio company West is described only as healthcare infrastructure. There is not enough information to classify it. Mark “unknown” and name the missing product or customer evidence. Treating West as safe because its description is vague rewards poor data.

This fictional exercise changes disclosure, not the truth of the companies' businesses. It also prevents a common shortcut: excluding North while casually sharing detailed information with the less-understood West.

Check the partner and ask early

Find out who would review your material and who works with the overlapping portfolio company. A different partner's name does not settle information access or firm policy. Ask the firm to explain its process, including who will see the deck and whether the relationship creates a reason to pause. Save the dated answer with your review.

Use this copyable first-message script:

Before sending our detailed deck, I noticed your investment in [company].
We serve [buyer] by [workflow]; the apparent overlap is [specific point].
Would your team see a conflict in reviewing us? Who would receive our
materials, and how would information be handled across the relevant teams?
I can begin with our public overview while we clarify this.

To identify the underlying investment trail, use the competitor-backer research method. Keep discovery separate from the disclosure decision.

Choose the next action

Use three disclosure states:

• Public overview is reasonable: explain the company at the level already available publicly, while continuing normal diligence.
• Ask first: mention the relevant portfolio overlap and ask whether the firm sees a conflict and how it handles information.
• Hold sensitive material: the supplied facts indicate direct overlap, unresolved obligations, or a reason you are uncomfortable proceeding.

Do not use a numerical fit score to override the last state. A strong sector match does not answer a confidentiality question. Equally, “hold” need not mean delete the investor forever. Preserve the reason and the evidence that would allow reconsideration.

The failure case: false reassurance

The dangerous output is “cleared” based on a logo wall and two category labels. It implies a completeness you have not established. A better result is bounded: what you checked, what overlap you found, what is unknown, and what you will share next.

Keep the review with the investor evidence scorecard. If overlap is manageable, return to thesis fit, identify the right person through the partner map, and prepare the remaining questions with diligence before the call. A useful shortlist is one you can act on thoughtfully, not one stripped of every investor who understands your market.

For the broader shortlist decision, use the investor-match review. Bring your company context to Find investors for your startup, then retain any unresolved disclosure question alongside each candidate.

FAQ

Is every company in the same sector a conflict?

No. Compare the buyer, workflow and substitution decision. Two products can serve the same industry while solving different problems with separate budgets.

Should I ask before sending the deck?

Ask first when you have identified a plausible direct overlap or the material contains commercially sensitive detail. A public overview can start the clarification conversation.

Does approaching a different partner resolve the conflict?

That requires confirmation of the firm's process. Establish who handles the portfolio relationship, who will review your company and how information is shared.

What if the portfolio page lists no competitor?

Record which pages you checked and ask about the relevant overlap. A public showcase may be incomplete; an absent logo does not establish clearance.

Can a historical investment still matter?

Yes, it can justify a question about the relationship and current obligations. Check the investment date, present relationship and current product overlap instead of treating an old logo as either an automatic block or a clearance.

Method and limits

Updated 14 October 2026. ClinicFlow, North, East and West are fictional examples; the four comparison dimensions are an editorial framework. The linked First Round and a16z policy references are retained from the prior article and were not rechecked in this offline refresh. Confirm current policy with the firm; this workflow provides no contractual interpretation or legal clearance. Keep source checks consistent with the research methodology.

Prepared with AI assistance from linked primary sources. Workflows are editorial guidance; examples are fictional. Not financial or legal advice.